Helicobacter

Papers
(The TQCC of Helicobacter is 10. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2022-08-01 to 2026-08-01.)
ArticleCitations
Gastric Helicobacter pylori infection does not contribute to extraoral halitosis and its eradication cannot achieve substantial reduction of halitosis96
Issue Information93
Second‐ and Third‐Line Therapies for Helicobacter pylori Eradication in Slovenia: Data From 2013–2023 of the European Registry on 65
DNA starvation/stationary phase protection protein of Helicobacter pylori as a potential immunodominant antigen for infection detection53
UreBimmunodominant epitope‐specificCD8+T‐cell responses were beneficial in reducing gastric symptoms inHelicobacter pylori‐infected individuals52
A “new” option in Helicobacter pylori eradication: High‐dose amoxicillin dual therapy outperforms bismuth quadruple therapy in a high dual resistance setting50
Expansion of cagA Copy Number in Helicobacter pylori During Co‐Infection in a Mouse Model50
Indications of Helicobacter pylori Eradication Treatment and Its Influence on Prescriptions and Effectiveness (Hp‐ EuReg 49
Worldwide Phylogenetic and Clinical Risk Association of the Helicobacter pylori Outer Membrane Gen48
Low‐dose or high‐dose amoxicillin in vonoprazan‐based dual therapy for Helicobacter pylori eradication? A systematic review and meta‐analysis45
Tegoprazan‐Amoxicillin Dual Therapy for Helicobacter pylori Eradication: A Prospective, Randomized, Multicenter Study in Fujian, China43
A real‐world exploratory study on the feasibility of vonoprazan and tetracycline dual therapy for the treatment of Helicobacter pylori infection in special populations with penicillin allergy o41
Proteomic Profiling of Extracellular Vesicles Reveals Potential Biomarkers for Helicobacter pylori Infection and Gastric Cancer40
Evidence‐Based Guidelines for the Diagnosis and Treatment of Helicobacter pylori Infection in Korea: 2025 Revised Edition39
Efficacy and safety of minocycline quadruple therapy for Helicobacter pylori eradication: A meta‐analysis of RCTs36
Optimal Duration of Bismuth‐Containing Quadruple Therapy for Helicobacter pylori Eradication: A Systematic Review and Meta‐Analysis35
34
Issue Information29
Seroprevalence of Helicobacter pylori infection among schoolchildren in southern Taiwan—A 20‐year longitudinal follow‐up29
Droplet Digital PCR ‐Based Detection of Clarithromycin Resistance on Rapid Urease Test Samples Predicts 26
Bismuth, esomeprazole, metronidazole and amoxicillin or tetracycline as a first‐line regimen for Helicobacter pylori eradication: A randomized controlled trial26
Letter to the Editor regarding the article: “Forty years of Helicobacter pylori infection and changes in findings at esophagogastroduodenoscopy”25
Roles of Gastric Non‐Helicobacter pylori Helicobacter Species in Gastric Disease Development: A Review25
Nationwide survey ofHelicobacter pyloriseropositivity and gastric atrophy in Zambia24
Helicobacter pylori , Inflammation, and Long‐Term Outcome in Patients With Acute Myocardial Infarction: A Prospective Cohort Study24
Prophylactic immunization to Helicobacter pylori infection using spore vectored vaccines23
EUROHELICAN —Accelerating Gastric Cancer Reduction Through Helicobacter pylori 23
Managing Helicobacter pylori as an Infectious Disease: Implementation of Antimicrobial Stewardship22
Innate Immunity in Helicobacter pylori Infection and Gastric Oncogenesis22
Efficacy of Tegoprazan‐Containing Sequential Eradication Treatment Compared to Esomeprazole‐Containing Sequential Eradication of Helicobacter pylori in South Korea, a Region With High Antimicro22
Exosome‐Based Detection of Helicobacter pylori Infection and Clarithromycin Resistance in Children21
Efficacy of bismuth for antibiotic‐resistant Helicobacter pylori strains eradication: A systematic review and meta‐analysis21
Efficacy and Safety of Levofloxacin‐ Versus Moxifloxacin‐Based Nitazoxanide Quadruple Therapy as Second‐Line Treatment for Helicobacter pylori 21
Perspectives from recent advances of Helicobacter pylori vaccines research21
Whole genome sequencing reveals novel genetic mutations of Helicobacter pylori associating with resistance to clarithromycin and levofloxacin21
Cardia and non‐cardia gastric cancer risk associated with Helicobacter pylori in East Asia and the West: A systematic review, meta‐analysis, and estimation of population attributable fraction20
20
Tegoprazan‐Based Triple Therapy for Helicobacter pylori Eradication: A Phase <20
Assessing the Capabilities of Novel Open‐Source Artificial Intelligence—DeepSeek in Helicobacter pylori‐Related Queries19
Authors' Reply to the Letter on “Is Tailored Bismuth Quadruple Therapy (With Clarithromycin or Furazolidone) Based on Fecal Molecular Susceptibility Testing in First‐Line Helicobacter pylori Er19
Helicobacter pylori and Impaired Early Childhood Development—Evidence From a Birth Cohort Study From Ghana and Côte d'Ivoire19
Association between genetic polymorphisms of NOD1, Interleukin‐1B, and cagA strain with low‐grade duodenal eosinophilia in Helicobacter pylori‐related dyspepsia19
Characterization of Fecal Microbial Communities in Patients With Type 2 Diabetes Mellitus Combined With Helicobacter pylori Infection18
Development and Evaluation of a Multi‐Epitope Vaccine Based on P22 Virus‐Like Particles Targeting Helicobacter pylori18
Host Genetic Variants Associated With Helicobacter pylori Infection: A Meta‐Analysis Combined With18
Effect of Helicobacter pylori infection and its eradication on the expression of tight junction proteins in the gastric epithelium in relation to gastric carcinogenesis18
Efficacy and Safety of Keverprazan–Amoxicillin Dual Regimen in Initial Eradication of Helicobacter pylori 17
A Bidirectional Association Between Helicobacter pylori Infection and Hyperlipidemia: Clinical Evidence and Mechanistic Insights16
Efficacy of Three Amoxicillin Doses in Vonoprazan Dual Therapy for Helicobacter pylori Eradication: A Randomized Noninferiority Trial16
Vonoprazan and amoxicillin dual therapy as the first‐line treatment of Helicobacter pylori infection: A systematic review and meta‐analysis16
Efficacy of Bismuth Quadruple Therapy in the Treatment of Helicobacter pylori‐Infected Peptic Ulcer Children in Vietnam16
Helicobacter pylori infection prevalence in ambulatory settings in 2017–2019 in RUSSIA: The data of real‐world national multicenter trial16
Characteristics of phenotypic antibiotic resistance of Helicobacter pylori and its correlation with genotypic antibiotic resistance: A retrospective study in Ningxia15
The Association of a Positive Fecal Immunochemical Test With the Risk of Gastroesophageal Cancer: An Age‐Sex‐ H. Pylori Exposure Matched Cohort Study and14
Disruption of the gastric epithelial barrier in Correa's cascade: Clinical evidence via confocal endomicroscopy14
Helicobacter pylori infection found during upper endoscopy performed for the diagnosis of celiac, inflammatory bowel diseases, and eosinophilic esophagitis: A multicenter pediatric European stu14
Inquiry about methodology used to isolate multiple Helicobacter pylori strains from the same patient14
Molecular detection of Helicobacter pylori and its genotypic antimicrobial resistance patterns in dyspeptic Mozambican patients14
Effect of Lactobacillus gasseri BIO 6369 and Lacticaseibacillus rhamnosus <14
The expression and function of theB7family inHelicobacter pyloriinfection and gastric carcinogenesis process14
An Economic Evaluation of Family‐Based Versus Traditional Helicobacter pylori Screen‐and‐Treat Strategy: Based on Real‐World Data and Microsimulation Mod14
Boosting the Anti‐ Helicobacter Efficacy of Azithromycin through Natural Compounds: Insights From In Vitro, In Vivo, Histopathological, and Molecular Doc14
Changes of Helicobacter pylori Infection Status and Risk of Precancerous Lesions: A Prospective Cohort Study in Chinese Population13
Effect of Helicobacter pylori eradication on gastric precancerous lesions: A systematic review and meta‐analysis13
Elucidating the Pathogenic Role of Helicobacter pylori Infection in Hematologic Disorders: Mechanistic Insights and Future Perspectives13
Interpretation the Results of Eradicating Helicobacter pylori Infection Causing Colorectal Cancer Could Be Cautious13
Efficacy and Safety of Vonoprazan‐Based Dual, Triple, and Quadruple Therapies for Helicobacter pylori 13
Preventive effect of Helicobacter pylori eradication on the coronary heart diseases depending on age and sex with a median follow‐up of 51 months13
Issue Information13
The Gastric Microbiota Invade the Lamina Propria in Helicobacter pylori ‐Associated Gastritis and Precancer13
Effects of prior antibiotic use on clarithromycin resistance in Helicobacter pylori13
Reevaluating the Adverse Events With the Same‐Dosage Regimen in Hemodialysis Patients Undergoing Helicobacter pylori Eradication12
The Interplay Between Helicobacter pylori and Suppressors of Cytokine Signaling (SOCS) Molecules in the Development of Gastric Cancer and Induction of Immune Response12
Letter to the Editor: Efficacy of Lactobacillus spp. Supplementation in Helicobacter pylori Eradication: A Systematic Meta‐Analysis of Randomized Controlled Trials With Trial Sequential 12
Correlation of FUT3 and FUT6 Gene Polymorphisms With Helicobacter pylori 12
Antimicrobial screening involving Helicobacter pylori of nano‐therapeutic compounds based on the amoxicillin antibiotic drug12
 12
Urolithin B alleviates Helicobacter pylori‐induced inflammation and oxidative stress in mice12
Gastric Cancer Endoscopic Screening in an Intermediate‐Risk Country—A Dual‐Center Pilot Program12
Antibiotic Combinations in Bismuth‐Containing Quadruple Therapy for Helicobacter pylori Eradication: A Systematic Review and Network Meta‐Analysis12
After 28 Years, Professor David Y. Graham Says Goodbye and Helicobacter Welcomes a New Editor12
Concentration‐dependent effect of amoxicillin against clinical strains of Helicobacter pylori11
Evaluating the potency of zoliflodacin against Helicobacter pylori: In vitro activity and conserved GyrB target11
Issue Information11
Histopathologically defined intestinal metaplasia in lesser curvature of corpus prior to Helicobacter pylori eradication is a risk factor for gastric cancer development11
Optimizing Benefits‐Harms of H. pylori Screen‐and‐Treat Programs Tailored to the Regional Settings11
Efficacy and Safety of Tegoprazan‐Based Dual, Triple, and Quadruple Therapies in First‐Line Helicobacter pylori 11
Exploring the capacities of ChatGPT: A comprehensive evaluation of its accuracy and repeatability in addressing helicobacter pylori‐related queries11
Persistent advanced periductal fibrosis is and helicobacter pylori infection in post‐treatment of opisthorchiasis: Correspondence11
Cost‐Effectiveness of Population‐Based Helicobacter pylori Screening With Eradication for Optimal Age of Implementation11
Advances in Helicobacter pylori vaccine research: From candidate antigens to adjuvants—A review11
Real‐World Effectiveness and Safety of Saccharomyces boulardii CNCM I‐745 as Adjunct Therapy for 11
Efficacy and Safety of Vonoprazan in Dual/Triple/Quadruple Regimens Both in First‐Line and Rescue Therapy for Helicobacter pylori Eradication: A Systematic Review With Meta‐Analysis11
Reply: Is Tailored Bismuth Quadruple Therapy (With Clarithromycin or Furazolidone) Based on Fecal Molecular Susceptibility Testing in First‐Line Helicobacter pylori Eradication Treatment More E11
Optimizing Duration and Dosing Frequency of Vonoprazan–Amoxicillin Dual Therapy for Helicobacter pylori: A Multicenter Randomized Trial11
Resilience of the Gut Microbiome to Short Proton Pump Inhibitor Therapy With or Without High‐Dosage L. reuteri in H. pylori 11
Efficacy and Safety of Vonoprazan‐Based Dual Therapies With Different Antibiotics Versus Bismuth‐Containing Quadruple Therapy for Helicobacter pylori10
Primary antibiotic resistance of Helicobacter pylori in India over the past two decades: A systematic review10
Helicobacter pylori infection and rheumatoid arthritis as risk enhancers' factors for atherosclerotic cardiovascular diseases10
Do atrophic gastritis and intestinal metaplasia reverse after Helicobacter pylori eradication?10
Helicobacter pyloriCagA Promotes the Formation of Gallstones by Increasing the Permeability of Gallbladder Epithelial Cells10
Helicobacter pylori‐positive chronic atrophic gastritis and cellular senescence10
Helicobacter hepaticus promotes liver fibrosis through oxidative stress induced by hydrogenase in BALB/c mice10
Comparison between the GastroPanel test and the serum pepsinogen assay interpreted with the ABC method—A prospective study10
Development of a modified ABC method among Helicobacter pylori infected but serum pepsinogen test‐negative individuals10
Current role of tailored therapy in treating Helicobacter pylori infections. A systematic review, meta‐analysis and critical analysis10
Empirical Therapy Versus Tailored Therapy of Helicobacter pylori in Korea: Results of the K‐ CREATE St10
Interactions between Helicobacter pylori infection and host metabolic homeostasis: A comprehensive review10
10
Research trends on vonoprazan‐based therapy for Helicobacter pylori eradication: A bibliometric analysis from 2015 to 202310
0.16945099830627